Reports
Sale
Global Cardiovascular and Soft Tissue Repair Patches Market: By Type: EPTFE, Biomaterial, Tissue Engineered Material; By Application: Cardiac Repair, Vascular Repair, Pericardial Repair, Dural Repair, Soft Tissue Repair; By End User: Hospitals, Clinics, Other end-Users; Regional Analysis; Supplier Landscape; 2024-2032
Global Cardiovascular and Soft Tissue Repair Patches Market Outlook
The global cardiovascular and soft tissue repair patches market size was valued at USD 4.54 billion in 2023. The market is being driven by the rising prevalence of cardiovascular and chronic diseases, development of the healthcare sector, and the increasing number of surgeries. The market is anticipated to grow at a CAGR of 8.2% during the forecast period 2024-2032 to reach a value of USD 9.24 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Key Trends in the Market
Cardiovascular and soft tissue repair patches refer to various methods used by surgeons and doctors to treat the root cause of cardiovascular disease and repair the injured tissues. Soft tissue repair refers to the repair of muscle, blood vessels, fibrous tissue, and/or supporting connective tissues. Numerous biomaterials can be used in the repair and replacement of impaired tissues.
- The increasing collaborative activities among the established market players, pharmaceutical companies, and raw material suppliers for the development of novel technologies and innovative products using tissue engineered materials is a major trend in the cardiovascular and soft tissue repair patches market.
- Abdominal wall hernias are among the most common type of hernias found across all ages. The rising incidence of hernias, such as umbilical hernias, congenital diaphragmatic hernias, inguinal hernias, and ventral hernias, is anticipated to fuel the demand for cardiovascular and soft tissue repair patches.
- The growing geriatric population is a significant factor propelling the market for cardiovascular and soft tissue repair patches. This can be attributed to the fact that elderly people are prone to diseases related to the heart and stomach.
Opportunities and Challenges in the Market
There has been a rise in the number of cardiovascular cases and congenital heart diseases across the globe. Major players in the market are focusing on the acquisition of companies and collaboration with other players to propel research and development and bring innovations to the market. Governments of multiple countries have also started to promote collaborations and provide support to medical organisatons, which is likely to favour the cardiovascular and soft tissue repair patches market growth.
However, the market can face some challenges in under developed regions due to a lack of awareness and misconceptions related to treatment methods.
Global Cardiovascular and Soft Tissue Repair Patches Market Analysis
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on raw materials, the market can be segmented into ePTFE and biomaterial and tissue engineered materials, among others. Based on the application, it can be segmented into cardiac repair, vascular repair and reconstruction, pericardial repair, dural repair, and soft tissue repair. The regional markets for cardiovascular and soft tissue repair patches include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
The comprehensive EMR report provides an in-depth assessment of the market based on Porter's five forces model along with giving a SWOT analysis. The report gives a detailed analysis of the following key players in the global cardiovascular and soft tissue repair patches market, covering their competitive landscape and the latest developments like mergers, acquisitions, investments, and expansion plans.
- B. Braun SE
- LeMaitre Vascular, Inc
- Baxter
- CryoLife, Inc.
- CorMatrix, Inc.
- Glycar SA.
- W. L. Gore & Associates, Inc.
- Vascudyne, Inc.
- Others
Market Segmentation by Application
The soft tissue repair segment is estimated to witness a healthy growth in the coming years, accounting for a significant cardiovascular and soft tissue repair patches market share. There is a considerable increase in the incidences of hernias, including congenital diaphragmatic hernias, ventral hernias, umbilical hernias, and inguinal hernias, among others. With the increasing prevalence of hernias, the demand for tissue repair patches in therapeutic treatments is expected to rise, as this helps treat hernia disorders more effectively.
Market Categorisation based on Raw Material
ePTFE is widely used as a raw material in the production of medical accessories such as dressings, ostomy bags, face masks, drainage bags, urine bags, and enclosures for medical devices, among others.
The ePTFE segment is likely to dominate the cardiovascular and soft tissue repair patches market. The rapid growth of the segment can be attributed to ePTFE's many advantages, including its high tensile strength, high durability, and ease of supply.
Market Share by Region
North America holds a leading position and is expected to account for a significant revenue share of the cardiovascular and soft tissue repair patches market. The regional market growth is the result of evolving lifestyles, rising cases of cardiovascular disorders and other ailments due to increasing obesity rates, high level of alcohol consumption.
Key product releases, a high concentration of market participants, and the presence of manufacturers in the US are some of the factors boosting the market growth in the region.
Meanwhile, due to the rising rates of cardiac diseases, rapid economic growth of nations such as China and India, and rising popularity of surgery methods that are minimally invasive, the Asia Pacific is projected to experience the fastest growth rate over the coming years. The Asian countries like China and India are likely to provide ample growth opoortunities for the market expansion due to the rapid development of the healthcare infrastructure, growing medical tourism, and increasing geriatric population in the countries.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Competitive Landscape
B. Braun SE is one of the world’s leading medical equipment manufacturing companies which aims to innovate the healthcare field to improve and protect the health of people around the world. The company has been active in the healthcare sector since 1839 and its headquarter is located in Melsungen, Germany. The company provides various solutions and systems such as trocar systems, ligation clips, light sources, anaesthetic tools, wound closure, blood glucose monitoring, insulin injection, and suction equipment.
LeMaitre Vascular, Inc. is a leading global innovator, manufacturer, and provider of treatment for peripheral vascular diseases that affect millions of people around the world. The company has a wide variety of products including Aortic, AV Access, Cardiac, Carotid, Lower Extremity, and Neuro, among others.
Baxter is a leading healthcare company whose main areas of focus include chronic and urgent medical issues, including kidney illness. The company’s portfolio of acute, nutritional, and hospital and surgical care products help improve healthcare services around the world. The firm specialises in several sectors, including pharmacy automation, anaesthesia, biosurgery, and medical devices.
Other cardiovascular and soft tissue repair patches market players include CryoLife, Inc., CorMatrix, Inc., Glycar SA., W. L. Gore & Associates, Inc., and Vascudyne, Inc., among others.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Cardiovascular and Soft Tissue Repair Patches Market Overview
3.1 Cardiovascular and Soft Tissue Repair Patches Market Historical Value (2017-2023)
3.2 Cardiovascular and Soft Tissue Repair Patches Market Forecast Value (2024-2032)
4 Cardiovascular and Soft Tissue Repair Patches Market Landscape
4.1 Cardiovascular and Soft Tissue Repair Patches: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Cardiovascular and Soft Tissue Repair Patches: Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Technology
4.2.3 Analysis by End user
5 Cardiovascular and Soft Tissue Repair Patches Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Cardiovascular and Soft Tissue Repair Patches Market Segmentation
6.1 Cardiovascular and Soft Tissue Repair Patches Market by Type
6.1.1 Market Overview
6.1.2 EPTFE
6.1.3 Biomaterial
6.1.4 Tissue Engineered Material
6.2 Cardiovascular and Soft Tissue Repair Patches Market by Application
6.2.1 Cardiac Repair
6.2.2 Vascular Repair
6.2.3 Pericardial Repair
6.2.4 Dural Repair
6.2.5 Soft Tissue Repair
6.3 Cardiovascular and Soft Tissue Repair Patches Market by End User
6.3.1 Market Overview
6.3.2 Hospitals
6.3.3 Clinics
6.3.4 Other end-Users
6.4 Cardiovascular and Soft Tissue Repair Patches Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Cardiovascular and Soft Tissue Repair Patches
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Cardiovascular and Soft Tissue Repair Patches
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Cardiovascular and Soft Tissue Repair Patches
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Cardiovascular and Soft Tissue Repair Patches
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Cardiovascular and Soft Tissue Repair Patches
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by NIH Departments
14.7 Analysis by Recipient Organization
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 CryoLife, Inc
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Edwards Lifesciences Corporation (U.S)
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Bard Peripheral Vascular
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Baxter
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Anteris
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Neovasc Inc.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Southernlight Biomaterials
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Medtronic plc
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 GETINGE AB
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 W. L. Gore & Associates, Inc.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Abbott
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 LeMaitre Vascular Inc.
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
18 Cardiovascular and Soft Tissue Repair Patches - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The global cardiovascular and soft tissue repair patches market reached a value of USD 4.54 billion in 2023.
The market is projected to grow at a CAGR of 8.2% during the forecast period of 2024-2032 to reach a value of USD 9.24 billion by 2032.
The market is being driven by the rising prevalence of cardiovascular and chronic diseases, development of the healthcare sector, and the increasing number of surgeries.
The growing number of collaborations among the market players and the increasing focus of companies on R&D to bolster product innovation are the key trends expected to aid the market.
The major regional markets of the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
The raw materials available in the market include ePTFE and biomaterial and tissue engineered materials, among others.
The different applications of the product include cardiac repair, vascular repair and reconstruction, pericardial repair, dural repair, and soft tissue repair.
The key players in the global cardiovascular and soft tissue repair patches market include B. Braun SE, LeMaitre Vascular, Inc, Baxter, CryoLife, Inc., CorMatrix, Inc., Glycar SA., W. L. Gore & Associates, Inc., and Vascudyne, Inc., among others.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER